Utilizing drug-target-event relationships to unveil safety patterns in pharmacovigilance
Research output: Contribution to journal › Journal article › Research › peer-review
Standard
Utilizing drug-target-event relationships to unveil safety patterns in pharmacovigilance. / Hauser, Alexander Sebastian; Kooistra, Albert Jelke; Sverrisdóttir, Eva; Sessa, Maurizio.
In: Expert Opinion on Drug Safety, Vol. 19, 2020, p. 961-968.Research output: Contribution to journal › Journal article › Research › peer-review
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - Utilizing drug-target-event relationships to unveil safety patterns in pharmacovigilance
AU - Hauser, Alexander Sebastian
AU - Kooistra, Albert Jelke
AU - Sverrisdóttir, Eva
AU - Sessa, Maurizio
PY - 2020
Y1 - 2020
N2 - INTRODUCTION: Signal detection is the most pivotal activity of signal management to guarantee that drugs maintain a positive risk-benefit ratio during their lifetime on the market. Signal detection is based on the systematic evaluation of available data sources, which have recently been extended in order to improve timely and comprehensive signal detection of drug safety problems.AREAS COVERED: In recent years, attempts have been made to incorporate pharmacological data for the prediction of safety signals. Previous studies have shown that data on the pharmacological targets of drugs are predictive of post-marketing adverse events. However, current approaches limit such predictions to adverse events expected from the interaction of a drug with the main pharmacological target and do not take off-target interactions into consideration.EXPERT OPINION: The authors propose the application of predictive modelling techniques utilizing pharmacological data from public databases for predicting drug-target-event relationships deriving from main- and off-target binding and from which potential safety signals can be deduced. Additionally, they provide an operative procedure for the identification of clinically relevant subgroups for predicted safety signals.
AB - INTRODUCTION: Signal detection is the most pivotal activity of signal management to guarantee that drugs maintain a positive risk-benefit ratio during their lifetime on the market. Signal detection is based on the systematic evaluation of available data sources, which have recently been extended in order to improve timely and comprehensive signal detection of drug safety problems.AREAS COVERED: In recent years, attempts have been made to incorporate pharmacological data for the prediction of safety signals. Previous studies have shown that data on the pharmacological targets of drugs are predictive of post-marketing adverse events. However, current approaches limit such predictions to adverse events expected from the interaction of a drug with the main pharmacological target and do not take off-target interactions into consideration.EXPERT OPINION: The authors propose the application of predictive modelling techniques utilizing pharmacological data from public databases for predicting drug-target-event relationships deriving from main- and off-target binding and from which potential safety signals can be deduced. Additionally, they provide an operative procedure for the identification of clinically relevant subgroups for predicted safety signals.
U2 - 10.1080/14740338.2020.1780208
DO - 10.1080/14740338.2020.1780208
M3 - Journal article
C2 - 32510245
VL - 19
SP - 961
EP - 968
JO - Expert Opinion on Drug Safety
JF - Expert Opinion on Drug Safety
SN - 1474-0338
ER -
ID: 242774374